MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹7,745 Cr | ₹684,750 Cr | ₹5,791 Cr | ₹457 Cr | ₹44,272 Cr |
What is the latest Total Expenditure of MANKIND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹7,745 Cr |
| Mar2024 | ₹684,750 Cr |
| Mar2023 | ₹5,791 Cr |
| Mar2022 | ₹457 Cr |
| Mar2021 | ₹44,272 Cr |
How is Total Expenditure of MANKIND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,745 Cr | -98.87 | |
| Mar2024 | ₹684,750 Cr | 11,724.37 | |
| Mar2023 | ₹5,791 Cr | 1,168.48 | |
| Mar2022 | ₹457 Cr | -98.97 | |
| Mar2021 | ₹44,272 Cr | - | |
Compare Total Expenditure of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹103,842.3 Cr | 0.4% | 14.5% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹453,750.0 Cr | 0.6% | 13.6% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,117.0 Cr | 1.5% | 9.1% | 9.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,314.0 Cr | 1.5% | 8.2% | 35.7% | Stock Analytics | |
| CIPLA | ₹113,225.0 Cr | -2.1% | 13.7% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,037.0 Cr | -1.4% | 8% | 7.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.4% |
14.5% |
0.6% |
| SENSEX | -0.3% |
-4.3% |
-8.9% |
You may also like the below Video Courses